MRI perfusion measurements calculated using advanced deconvolution techniques predict survival in recurrent glioblastoma treated with bevacizumab
Crossref DOI link: https://doi.org/10.1007/s11060-015-1755-8
Published Online: 2015-03-15
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Harris, Robert J.
Cloughesy, Timothy F.
Hardy, Anthony J.
Liau, Linda M.
Pope, Whitney B.
Nghiemphu, Phioanh L.
Lai, Albert
Ellingson, Benjamin M.
Text and Data Mining valid from 2015-03-15